Cho Sang-rae is the founder of Gencurix. Gencurix has raised $60M in total funding. Latest round: IPO. Based in Seoul, South Korea.
Sang Rae Cho is the CEO of Gencurix, a South Korea-based cancer molecular diagnostics company. Gencurix is headquartered in Seoul and is listed on KOSDAQ. The company has described itself as the first Asian company to develop a prognostic diagnostic test for breast cancer.
Full founder directory · Investor directory · Company funding database · Fundraising library